Evidence map›Paper›PMID 35582465›Full record

ReviewWorld journal of cardiology2022

Role of cardiac magnetic resonance imaging in troponinemia syndromes.

Nhung Nguyen Nguyen, Joseph George Assad, Giuseppe Femia, Andreas Schuster, James Otton, Tuan Le Nguyen

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nhung Nguyen NguyenDepartment of Cardiology, Liverpool Hospital, Liverpool 2170, NSW, Australia.
Joseph George AssadDepartment of Cardiology, Liverpool Hospital, Liverpool 2170, NSW, Australia.
Giuseppe FemiaDepartment of Cardiology, Campbelltown Hospital, Campbelltown 2560, NSW, Australia.
Andreas SchusterDepartment of Cardiology and Pneumology, University Medical Center, Göttingen 37075, Germany.
James OttonDepartment of Cardiology, Liverpool Hospital, Liverpool 2170, NSW, Australia.
Tuan Le NguyenDepartment of Cardiology, Liverpool Hospital, Liverpool 2170, NSW, Australia. nguyenletuan@hotmail.com.
Liverpool Hospital · AUCamden and Campbelltown Hospitals · AUUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac magnetic resonance imaging (MRI) is an evolving technology, proving to be a highly accurate tool for quantitative assessment. Most recently, it has been increasingly used in the diagnostic and prognostic evaluation of conditions involving an elevation in troponin or troponinemia. Although an elevation in troponin is a nonspecific marker of myocardial tissue damage, it is a frequently ordered investigation leaving many patients without a specific diagnosis. Fortunately, the advent of newer cardiac MRI protocols can provide additional information. In this review, we discuss several conditions associated with an elevation in troponin such as myocardial infarction, myocarditis, Takotsubo cardiomyopathy, coronavirus disease 2019 related cardiac dysfunction and athlete's heart syndrome.

Indexed as

Athlete’s heartCardiac magnetic resonance imagingCOVID-19Myocardial infarctionMyocarditisTakotsubo cardiomyopathyTroponin

Identifiers

PMID35582465
PMCPMC9048277
OpenAlexW4224112797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.